Metsera, Inc. (NASDAQ:MTSR - Get Free Report) shares were down 9.4% on Thursday . The company traded as low as $23.19 and last traded at $23.36. Approximately 202,354 shares traded hands during trading, a decline of 64% from the average daily volume of 561,206 shares. The stock had previously closed at $25.78.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on MTSR shares. Guggenheim started coverage on shares of Metsera in a research note on Tuesday, February 25th. They set a "buy" rating and a $56.00 target price on the stock. Cantor Fitzgerald initiated coverage on shares of Metsera in a research note on Tuesday, February 25th. They set an "overweight" rating on the stock. Bank of America initiated coverage on shares of Metsera in a research note on Tuesday, February 25th. They issued a "buy" rating and a $38.00 price target on the stock. Finally, Evercore ISI initiated coverage on shares of Metsera in a research note on Tuesday, February 25th. They issued an "outperform" rating on the stock.
Read Our Latest Stock Analysis on Metsera
Metsera Trading Up 12.7 %
Metsera Company Profile
(
Get Free Report)
Metsera, Inc is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
Featured Articles
Before you consider Metsera, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Metsera wasn't on the list.
While Metsera currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
